• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Arrowhead Pharmaceuticals (ARWR)

Common Shares
Sell: $36.60|Buy: $38.50|Change: 0.40 (-1.05%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Address

177 East Colorado Boulevard
Suite 700
Pasadena
CA
USA
91105

Telephone

+1 646 304-3400

Website

https://www.arrowheadpharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-08-07T16:30:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Results for 20262026-08-07T00:00:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-05-12T16:30:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Results for 20262026-05-12T00:00:00
Arrowhead Pharmaceuticals Inc Annual General Meeting for 20252026-03-12T10:00:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-02-10T16:30:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Results for 20262026-02-10T00:00:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252025-11-26T16:30:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252025-11-26T00:00:00
Arrowhead Pharmaceuticals Inc Annual Report for 20252025-11-26T00:00:00

Previous key dates

NameKey Date
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T11:30:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T10:30:00
Cantor Global Healthcare Conference 20252025-09-04T09:10:00
Citi's 2025 Biopharma Back to School Conference2025-09-03T13:00:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-08-07T16:30:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Results for 20252025-08-07T00:00:00
46th Annual Goldman Sachs Global Healthcare Conference2025-06-09T14:00:00
Jefferies Global Healthcare Conference2025-06-04T09:20:00
BofA Securities 2025 Health Care Conference2025-05-14T11:20:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-05-12T16:30:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Result for 20252025-05-12T00:00:00
Arrowhead Pharmaceuticals Inc Annual General Meeting for 20242025-03-12T10:00:00
TD Cowen 45th Annual Health Care Conference2025-03-03T09:50:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-02-10T16:30:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Result for 20252025-02-10T00:00:00
7th Annual Evercore ISI HealthCONx Conference2024-12-04T14:10:00
Piper Sandler 36th Annual Healthcare Conference2024-12-03T13:30:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20242024-11-26T16:30:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Result for 20242024-11-26T00:00:00
Arrowhead Pharmaceuticals Inc Annual Report for 20242024-11-26T00:00:00
Arrowhead Pharmaceuticals Inc Jefferies London Healthcare Conference 20242024-11-20T08:00:00
Arrowhead Pharmaceuticals Inc UBS Global Healthcare Conference 20242024-11-12T15:30:00
Arrowhead Pharmaceuticals Inc. will participate 2024 Summer Series R&D Webinar: Central Nervous System – Platform and pipeline updates2024-10-07T16:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.